InsidersTradesSigma
Track the QLINEA share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, QLINEA has logged 1 public disclosures. Market capitalisation: €311.7m. The latest transaction was disclosed on 10 November 2025 (Purchase). Among the most active insiders: Karin Fischer. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
€9,070
1 ops.
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
Fundamental score
Ranked 29,000 of 29,062 companies
3.3
score / 100
Value4
Quality3
FCF yld-54%
Earn yld-59%
EV/EBITDA·
ROE-76%
Gross mgn-15%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 November 2025
Declarations1 total
4,000 shares@ €2.26750.0030% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026577520FI:A003T485-1
1 of 1 declaration
Acerca de QLINEA
QLINEA es una empresa centrada en el sector de la salud y farmacéutico, dedicada al desarrollo de soluciones innovadoras para el diagnóstico médico. Cotiza en la bolsa XSTO.